These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 15921033)

  • 1. Insulin-like growth factor I-mediated skeletal muscle hypertrophy is characterized by increased mTOR-p70S6K signaling without increased Akt phosphorylation.
    Song YH; Godard M; Li Y; Richmond SR; Rosenthal N; Delafontaine P
    J Investig Med; 2005 Apr; 53(3):135-42. PubMed ID: 15921033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endotoxin disrupts the leucine-signaling pathway involving phosphorylation of mTOR, 4E-BP1, and S6K1 in skeletal muscle.
    Lang CH; Frost RA
    J Cell Physiol; 2005 Apr; 203(1):144-55. PubMed ID: 15389631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.
    Rommel C; Bodine SC; Clarke BA; Rossman R; Nunez L; Stitt TN; Yancopoulos GD; Glass DJ
    Nat Cell Biol; 2001 Nov; 3(11):1009-13. PubMed ID: 11715022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The type 1 insulin-like growth factor receptor (IGF-IR) pathway is mandatory for the follistatin-induced skeletal muscle hypertrophy.
    Kalista S; Schakman O; Gilson H; Lause P; Demeulder B; Bertrand L; Pende M; Thissen JP
    Endocrinology; 2012 Jan; 153(1):241-53. PubMed ID: 22087027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A growth stimulus is needed for IGF-1 to induce skeletal muscle hypertrophy in vivo.
    Shavlakadze T; Chai J; Maley K; Cozens G; Grounds G; Winn N; Rosenthal N; Grounds MD
    J Cell Sci; 2010 Mar; 123(Pt 6):960-71. PubMed ID: 20179101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting.
    Song YH; Li Y; Du J; Mitch WE; Rosenthal N; Delafontaine P
    J Clin Invest; 2005 Feb; 115(2):451-8. PubMed ID: 15650772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.
    Khamzina L; Veilleux A; Bergeron S; Marette A
    Endocrinology; 2005 Mar; 146(3):1473-81. PubMed ID: 15604215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
    Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy.
    Nagai K; Matsubara T; Mima A; Sumi E; Kanamori H; Iehara N; Fukatsu A; Yanagita M; Nakano T; Ishimoto Y; Kita T; Doi T; Arai H
    Kidney Int; 2005 Aug; 68(2):552-61. PubMed ID: 16014032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
    Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
    Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MNK2 inhibits eIF4G activation through a pathway involving serine-arginine-rich protein kinase in skeletal muscle.
    Hu SI; Katz M; Chin S; Qi X; Cruz J; Ibebunjo C; Zhao S; Chen A; Glass DJ
    Sci Signal; 2012 Feb; 5(211):ra14. PubMed ID: 22337810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of caffeine on skeletal muscle anabolic signaling and hypertrophy.
    Moore TM; Mortensen XM; Ashby CK; Harris AM; Kump KJ; Laird DW; Adams AJ; Bray JK; Chen T; Thomson DM
    Appl Physiol Nutr Metab; 2017 Jun; 42(6):621-629. PubMed ID: 28177708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular transglutaminase 2 induces myotube hypertrophy through G protein-coupled receptor 56.
    Kitakaze T; Yoshikawa M; Kobayashi Y; Kimura N; Goshima N; Ishikawa T; Ogata Y; Yamashita Y; Ashida H; Harada N; Yamaji R
    Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118563. PubMed ID: 31666191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo.
    Bodine SC; Stitt TN; Gonzalez M; Kline WO; Stover GL; Bauerlein R; Zlotchenko E; Scrimgeour A; Lawrence JC; Glass DJ; Yancopoulos GD
    Nat Cell Biol; 2001 Nov; 3(11):1014-9. PubMed ID: 11715023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts.
    Cao X; Kambe F; Moeller LC; Refetoff S; Seo H
    Mol Endocrinol; 2005 Jan; 19(1):102-12. PubMed ID: 15388791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ataxia telangiectasia mutated impacts insulin-like growth factor 1 signalling in skeletal muscle.
    Ching JK; Luebbert SH; Collins RL; Zhang Z; Marupudi N; Banerjee S; Hurd RD; Ralston L; Fisher JS
    Exp Physiol; 2013 Feb; 98(2):526-35. PubMed ID: 22941977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanical Stimulation and IGF-1 Enhance mRNA Translation Rate in Osteoblasts Via Activation of the AKT-mTOR Pathway.
    Bakker AD; Gakes T; Hogervorst JM; de Wit GM; Klein-Nulend J; Jaspers RT
    J Cell Physiol; 2016 Jun; 231(6):1283-90. PubMed ID: 26505782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification.
    Pallafacchina G; Calabria E; Serrano AL; Kalhovde JM; Schiaffino S
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9213-8. PubMed ID: 12084817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of des IGF-1 on Erks, AKT-1 and P70 S6K activation in mouse skeletal and cardiac muscle.
    Li M; Li C; Parkhouse WS
    Mol Cell Biochem; 2002 Jul; 236(1-2):115-22. PubMed ID: 12190109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A functional insulin-like growth factor receptor is not necessary for load-induced skeletal muscle hypertrophy.
    Spangenburg EE; Le Roith D; Ward CW; Bodine SC
    J Physiol; 2008 Jan; 586(1):283-91. PubMed ID: 17974583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.